Key Takeaways:
- HJ Science prices IPO at HKD81.8 per share, seeking HKD1.02B in net proceeds
- Six cornerstone investors commit USD65M, including Taikang Life Insurance
- Trading begins June 23 on the Main Board under ticker 06132.HK
Back
HJ Science prices HKD81.8/share IPO with HKD1.02B proceeds
HJ SCIENCE-B (06132.HK) launched its Hong Kong IPO at HKD81.8 per share, targeting net proceeds of HKD1.02 billion.
The clinical-stage biotechnology company is offering 13.6 million H shares globally, with 10% reserved for Hong Kong retail investors and 90% for international placing, according to its prospectus. The offer period runs from today through noon on June 17, with the company expected to list on June 23.
Six cornerstone investors, including LBC HK, Sage Partners and Taikang Life Insurance, have collectively subscribed for shares equivalent to USD65 million. The sole sponsor is CITIC Securities. Each board lot comprises 100 shares, requiring an entry fee of approximately HKD8,262.
The pricing gives HJ Science an enterprise value that will be tested against sector peers when trading begins. First-day trading on June 23 will gauge institutional demand for the biotech listing amid a recovering Hong Kong IPO market.
This article is for informational purposes only and does not constitute investment advice.
